(Image: Getty/Sashkinw)

Biologics CDMO buys Shire Massachusetts facility

By Staff Reporter

Rentschler Biopharma will buy Shire’s development and manufacturing facility in Milton, Massachusetts, where the latter makes haemophilia A product, Obizur, for commercial production.

Shire offered to purchase all shares in Baxter spin-out Baxalta

Shire bids $30.6bn for Baxalta

By Fiona BARRY

Rare disease specialist Baxalta has advised shareholders to reject a second takeover offer from Shire, this time for $30.6bn.

Shire's Board succumbs to AbbVie's $53bn bid

Shire's Board succumbs to AbbVie's $53bn bid

By Dan Stanton

The acquisition of Shire for £31bn ($53bn) has moved a step closer but reliance on third party suppliers would only add two facilities to AbbVie's biomanufacturing network.